Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis
Yıl: 2023 Cilt: 47 Sayı: 1 Sayfa Aralığı: 44 - 60 Metin Dili: İngilizce DOI: 10.55730/1300-0152.2640 İndeks Tarihi: 22-03-2023
Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis
Öz: Breast and ovarian cancers are women’s most commonly diagnosed cancers. Seeking an efficient anticarcinogenic compound is still a top priority regarding the aggressiveness of these cancers and the limited benefit of current therapies. Hydroquinidine (HQ) is a natural alkaloid used in arrhythmia and Brugada syndrome. As an ion channel blocker, HQ exhibits its activity by altering ion gradient and membrane potential. Considering the growing evidence of ion channel blockers’ antineoplastic potential, we were prompted to test HQ’s effect on breast and ovarian cancers. MCF-7 and SKOV-3 cell lines were used to inspect how HQ acts on survival, clonogenicity, migration, tumorigenicity, proliferation, and apoptosis. The molecular basis for the remarkable antiproliferative and proapoptotic effect of HQ in these cells was dissected by proteomics. CDK1, PSMB5, PSMC2, MCM2, MCM7, YWHAH, YWHAQ, and YWHAB proteins in HQ-treated MCF-7 cells, and RRM2, PSMD2, PSME2, COX2, COX4l1, and CDK6 proteins in HQ-treated SKOV-3 cells were found as low-abundant, which was noteworthy. Based on the in-depth analysis, upon HQ treatment, several cell cycle-related processes were found as suppressed, whereas apoptosis and ferroptosis pathways were found to be activated. The observed proteome alteration in cancer cells may provide mechanistic explanations for the growth-limiting effects of HQ at the cellular level.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Afrasiabi E, Hietamäki M, Viitanen T, Sukumaran P, Bergelin N et al. (2010). Expression and significance of HERG (KCNH2) potassium channels in the regulation of MDA-MB-435S melanoma cell proliferation and migration. Cellular Signalling 22 (1): 57–64. https://doi.org/10.1016/j.cellsig.2009.09.010
- Akhtar N, Pradhan N, Barik GK, Chatterjee S, Ghosh S et al. (2020). Quinine-Based Semisynthetic Ion Transporters with Potential Antiproliferative Activities. ACS Applied Materials & Interfaces 12 (23): 25521–25533. https://doi.org/10.1021/acsami.0c01259
- Altamura C, Gavazzo P, Pusch M, Desaphy J-F (2022). Ion Channel Involvement in Tumor Drug Resistance. Journal of Personalized Medicine 12 (2): 210. https://doi.org/10.3390/jpm12020210
- Arcangeli A (2011). Ion channels and transporters in cancer. 3. Ion channels in the tumor cell-microenvironment cross talk. American Journal of Physiology. Cell Physiology 301 (4): C762-771. https://doi.org/10.1152/ajpcell.00113.2011
- Cerezo M, Rocchi S (2017). New anti-cancer molecules targeting HSPA5/BIP to induce endoplasmic reticulum stress, autophagy and apoptosis. Autophagy 13 (1): 216–217. https://doi.org/10.1 080/15548627.2016.1246107
- Chauffert B, Genne P, Gutierrez G, Mauvernay R-Y (1997). Therapeutic agents for the treatment of multiple drug resistance of cancers (United States Patent No. US5635515A). https://patents.google.com/patent/US5635515/en
- Chen C, Vincent J-D, Clarke IJ (1994). Ion channels and the signal transduction pathways in the regulation of growth hormone secretion. Trends in Endocrinology & Metabolism 5 (6): 227– 233. https://doi.org/10.1016/1043-2760(94)P3080-Q
- ChenY,MiY,ZhangX,MaQ,SongYetal.(2019).Dihydroartemisinin- induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells. Journal of Experimental & Clinical Cancer Research: CR 38: 402. https://doi.org/10.1186/s13046-019-1413-7
- Cortez AJ, Tudrej P, Kujawa KA, Lisowska KM (2018). Advances in ovarian cancer therapy. Cancer Chemotherapy and Pharmacology 81 (1): 17–38. https://doi.org/10.1007/s00280- 017-3501-8
- Crottès D, Jan L Y (2019). The multifaceted role of TMEM16A in cancer. Cell Calcium 82: 102050. https://doi.org/10.1016/j. ceca.2019.06.004
- Demircan T, Keskin I, Dumlu SN, Aytürk N, Avşaroğlu ME et al. (2017). Detailed tail proteomic analysis of axolotl (Ambystoma mexicanum) using an mRNA-seq reference database. PROTEOMICS 17 (1–2): 1600338. https://doi.org/10.1002/ pmic.201600338
- Demircan T, Yavuz M, Akgül S (2021). M6A Pathway Regulators Are Frequently Mutated in Breast Invasive Carcinoma and May Play an Important Role in Disease Pathogenesis. Omics: A Journal of Integrative Biology 25 (10): 660–678. https://doi. org/10.1089/omi.2021.0114
- Demircan T, Yavuz M, Kaya E, Akgül S, Altuntaş E (2021). Cellular and Molecular Comparison of Glioblastoma Multiform Cell Lines. Cureus 13 (6): e16043. https://doi.org/10.7759/ cureus.16043
- Deng M, Sun J, Xie S, Zhen H, Wang Y et al. (2019). Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin. Molecular Medicine Reports 20 (3): 2258. https:// doi.org/10.3892/mmr.2019.10477
- Du F, Zhao X, Fan D (2017). Soft Agar Colony Formation Assay as a Hallmark of Carcinogenesis. Bio-Protocol: 7 (12): e2351. https://doi.org/10.21769/BioProtoc.2351
- Duxbury MS, Whang EE (2007). RRM2 induces NF-κB-dependent MMP-9 activation and enhances cellular invasiveness. Biochemical and Biophysical Research Communications 354 (1): 190–196. https://doi.org/10.1016/j.bbrc.2006.12.177
- Eisa AA, De S, Detwiler A, Gilker E, Ignatious AC et al. (2019). YWHA (14-3-3) protein isoforms and their interactions with CDC25B phosphatase in mouse oogenesis and oocyte maturation. BMC Developmental Biology 19: 20. https://doi. org/10.1186/s12861-019-0200-1
- El-Battrawy I, Besler J, Li X, Lan H, Zhao Z et al. (2019). Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome. Frontiers in Pharmacology 10: 771. https://doi.org/10.3389/ fphar.2019.00771
- El-Mesery M, Seher A, El-Shafey M, El-Dosoky M, Badria FA (2021). Repurposing of quinoline alkaloids identifies their ability to enhance doxorubicin-induced sub-G0/G1 phase cell cycle arrest and apoptosis in cervical and hepatocellular carcinoma cells. Biotechnology and Applied Biochemistry 68 (4): 832– 840. https://doi.org/10.1002/bab.1999
- Erdem Kış E, Tiftik RN, Al Hennawi K, Ün İ (2022). The role of potassium channels in the proliferation and migration of endometrial adenocarcinoma HEC1-A cells. Molecular Biology Reports 49 (8): 7447–7454. https://doi.org/10.1007/ s11033-022-07546-3
- Fancello L, Kampen KR, Hofman IJF, Verbeeck J, Keersmaecker KD (2017). The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types. Oncotarget 8 (9): 14462–14478. https://doi.org/10.18632/oncotarget.14895
- Forsburg S L (2004). Eukaryotic MCM Proteins: Beyond Replication Initiation. Microbiology and Molecular Biology Review 68 (1): 109–131. https://doi.org/10.1128/MMBR.68.1.109-131.2004
- Gao R, Cao T, Chen H, Cai J, Lei M et al. (2019). Nav1.5-E3 antibody inhibits cancer progression. Translational Cancer Research 8 (1): 44–50. https://doi.org/10.21037/tcr.2018.12.23
- Giustetto C, Schimpf R, Mazzanti A, Scrocco C, Maury P et al. (2011). Long-Term Follow-Up of Patients With Short QT Syndrome. Journal of the American College of Cardiology 58 (6): 587–595. https://doi.org/10.1016/j.jacc.2011.03.038
- Hacıoğlu B, Kuş G, Kutlu HM, Kabadere S (2020). The effect of R547, a cyclin-dependent kinase inhibitor, on hepatocellular carcinoma cell death. Turkish Journal of Biology 44 (1): 24–33. https://doi.org/10.3906/biy-1907-3
- Hermida J-S, Denjoy I, Clerc J, Extramiana F, Jarry G et al. (2004). Hydroquinidine therapy in Brugada syndrome. Journal of the American College of Cardiology 43 (10): 1853–1860. https:// doi.org/10.1016/j.jacc.2003.12.046
- Hoffmann EK, Lambert IH (2014). Ion channels and transporters in the development of drug resistance in cancer cells. Philosophical Transactions of the Royal Society B: Biological Sciences 369 (1638): 20130109. https://doi.org/10.1098/ rstb.2013.0109
- Hu X, Bao M, Huang J, Zhou L, Zheng S (2020). Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma. Frontiers in Oncology 10: 541479
- Huang J, Chan WC, Ngai CH, Lok V, Zhang L et al. (2022). Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study. Cancers 14 (9): 2230. https://doi.org/10.3390/ cancers14092230
- Huang Q, Huang Q, Lin W, Lin J, Lin X (2010). Potential roles for PA28β in gastric adenocarcinoma development and diagnosis. Journal of Cancer Research and Clinical Oncology 136 (8): 1275–1282. https://doi.org/10.1007/s00432-010-0778-y
- Juvvadi PR, Moseley MA, Hughes CJ, Soderblom EJ, Lennon S et al. (2018). Scanning Quadrupole Data-Independent Acquisition, Part B: Application to the Analysis of the Calcineurin- Interacting Proteins during Treatment of Aspergillus fumigatus with Azole and Echinocandin Antifungal Drugs. Journal of Proteome Research 17 (2): 780–793. https://doi.org/10.1021/ acs.jproteome.7b00499
- Kundu N, Smyth MJ, Samsel L, Fulton AM (2002). Cyclooxygenase inhibitors block cell growth, increase ceramide and inhibit cell cycle. Breast Cancer Research and Treatment 76 (1): 57–64. https://doi.org/10.1023/a:1020224503335
- Kurnit KC, Fleming GF, Lengyel E (2021). Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment. Obstetrics & Gynecology 137 (1): 108–121. https://doi.org/10.1097/ AOG.0000000000004173
- Li J, Pang J, Liu Y, Zhang J, Zhang C et al. (2018). Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy. Oncology Reports 40 (1): 355–360. https://doi. org/10.3892/or.2018.6420
- Li M, Qi Y, Wei J, Lu L, Zhao X et al. (2017). N6-Isopentenyladenosine promoted HeLa cell apoptosis through inhibitions of AKT and transforming growth factor β–activated kinase 1 activation. Tumor Biology 39 (3): 1010428317695966. https://doi. org/10.1177/1010428317695966
- Li S, Dai X, Gong K, Song K, Tai F et al. (2019). PA28α/β Promote Breast Cancer Cell Invasion and Metastasis via Down- Regulation of CDK15. Frontiers in Oncology 9: 1283
- Li Y, Huang J, Zeng B, Yang D, Sun J et al. (2018). PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation. Cancer Letters 430: 109–122. https://doi.org/10.1016/j. canlet.2018.05.018
- Li Z, Huang L, Wei L, Zhang B, Zhong S et al. (2020). KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer. OncoTargets and Therapy 13: 10323–10333. https:// doi.org/10.2147/OTT.S268055
- Litan A, Langhans SA (2015). Cancer as a channelopathy: Ion channels and pumps in tumor development and progression. Frontiers in Cellular Neuroscience 9: 86. https://doi. org/10.3389/fncel.2015.00086
- Liu T, Zhang J, Chen H, Bianba T, Pan Y et al. (2022). PSMC2 promotes the progression of gastric cancer via induction of RPS15A/mTOR pathway. Oncogenesis 11 (1): 1–12. https:// doi.org/10.1038/s41389-022-00386-7
- Liu W, Qi Y, Liu L, Tang Y, Wei J et al. (2016). Suppression of tumor cell proliferation by quinine via the inhibition of the tumor necrosis factor receptor-associated factor 6-AKT interaction. Molecular Medicine Reports 14 (3): 2171–2179. https://doi. org/10.3892/mmr.2016.5492
- Liu Y, Chen H, Li X, Zhang F, Kong L et al. (2021). PSMC2 Regulates Cell Cycle Progression Through the p21/Cyclin D1 Pathway and Predicts a Poor Prognosis in Human Hepatocellular Carcinoma. Frontiers in Oncology 11: 607021.
- Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R et al. (2021). Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies— An Updated Review. Cancers 13 (17): 4287. https://doi. org/10.3390/cancers13174287
- McFadden DW, Riggs DR, Jackson BJ, Cunningham C (2006). Additive effects of Cox-1 and Cox-2 inhibition on breast cancer in vitro. International Journal of Oncology 29 (4): 1019–1023. https://doi.org/10.3892/ijo.29.4.1019
- Melkoumian ZK, Martirosyan AR, Strobl JS (2002). Myc protein is differentially sensitive to quinidine in tumor versus immortalized breast epithelial cell lines. International Journal of Cancer 102 (1): 60–69. https://doi.org/10.1002/ijc.10648
- Mercer BN, Begg GA, Page SP, Bennett CP, Tayebjee MH et al. (2016). Early Repolarization Syndrome; Mechanistic Theories and Clinical Correlates. Frontiers in Physiology 7: 266.
- Mohammed FH, Khajah MA, Yang M, Brackenbury WJ, Luqmanı YA (2015). Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cells. International Journal of Oncology 48 (1): 73–83. https://doi. org/10.3892/ijo.2015.3239
- Moo T-A, Sanford R, Dang C, Morrow M (2018). Overview of Breast Cancer Therapy. PET Clinics 13 (3): 339–354. https://doi. org/10.1016/j.cpet.2018.02.006
- Nilkaeo A, Bhuvanath S, Praputbut S, Wisessombat S (2006). Induction of cell cycle arrest and apoptosis in JAR trophoblast by antimalarial drugs. Biomedical Research 27 (3): 131–137. https://doi.org/10.2220/biomedres.27.131
- Nordlund P, Reichard P (2006). Ribonucleotide Reductases. Annual Review of Biochemistry 75 (1): 681–706. https://doi. org/10.1146/annurev.biochem.75.103004.142443
- Oliva CR, Markert T, Gillespie GY, Griguer CE (2015). Nuclear- encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas. Oncotarget 6 (6): 4330–4344.
- Payne SL, Ram P, Srinivasan DH, Le TT, Levin M et al. (2022). Potassium channel-driven bioelectric signalling regulates metastasis in triple-negative breast cancer. EBioMedicine 75: 103767. https://doi.org/10.1016/j.ebiom.2021.103767
- Perrin T, Guieu R, Koutbi L, Franceschi F, Hourdain J et al. (2018). Theophylline as an adjunct to control malignant ventricular arrhythmia associated with early repolarization. Pacing and Clinical Electrophysiology: PACE 41 (5): 444–446. https://doi. org/10.1111/pace.13240
- Qi Y, Pradipta AR, Li M, Zhao X, Lu L et al. (2017). Cinchonine induces apoptosis of HeLa and A549 cells through targeting TRAF6. Journal of Experimental & Clinical Cancer Research 36 (1): 35. https://doi.org/10.1186/s13046-017-0502-8
- Qi Y, Zhao X, Chen J, Pradipta AR, Wei J et al. (2019). In vitro and in vivo cancer cell apoptosis triggered by competitive binding of Cinchona alkaloids to the RING domain of TRAF6. Bioscience, Biotechnology, and Biochemistry 83 (6): 1011–1026. https:// doi.org/10.1080/09168451.2018.1559030
- Qiu Y-T, Wang W-J, Zhang B, Mei L-L, Shi Z-Z (2017). MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway. Oncology Reports 37 (6): 3590–3596. https://doi.org/10.3892/ or.2017.5614
- Qu K, Wang Z, Fan H, Li J, Liu J et al. (2017). MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma. Cell Death & Disease 8 (2): e2603. https://doi. org/10.1038/cddis.2016.352
- Roger S, Besson P, Le Guennec J-Y (2003). Involvement of a novel fast inward sodium current in the invasion capacity of a breast cancer cell line. Biochimica et Biophysica Acta (BBA) - Biomembranes 1616 (2): 107–111. https://doi.org/10.1016/j. bbamem.2003.07.001
- Rouzer CA, Marnett LJ (2009). Cyclooxygenases: Structural and functional insights. Journal of Lipid Research 50 (Suppl): S29– S34. https://doi.org/10.1194/jlr.R800042-JLR200
- Shen Y, Pan Y, Guo S, Sun L, Zhang C et al. (2020). The roles of mechanosensitive ion channels and associated downstream MAPK signaling pathways in PDLC mechanotransduction. Molecular Medicine Reports 21 (5): 2113–2122. https://doi. org/10.3892/mmr.2020.11006
- Sibai M, Altuntaş E, Süzek BE, Şahin B, Parlayan C et al. (2020). Comparison of protein expression profile of limb regeneration between neotenic and metamorphic axolotl. Biochemical and Biophysical Research Communications 522 (2): 428–434. https://doi.org/10.1016/j.bbrc.2019.11.118
- Sibai M, Parlayan C, Tuğlu P, Öztürk G, Demircan T (2019). Integrative Analysis of Axolotl Gene Expression Data from Regenerative and Wound Healing Limb Tissues. Scientific Reports 9 (1): 20280. https://doi.org/10.1038/s41598-019- 56829-6
- Solh M, Appel J, Dubay L, Lobocki C, Mittal V (2008). Quinine enhances the apoptotic and antiproliferative effects of Seocalcitol in breast cancer cell lines. Cancer Research 68 (9_ Supplement): 4028–4028.
- Sun H, Yang B, Zhang H, Song J, Zhang Y et al. (2019). RRM2 is a potential prognostic biomarker with functional significance in glioma. International Journal of Biological Sciences 15 (3): 533–543. https://doi.org/10.7150/ijbs.30114
- Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S et al. (2019). STRING v11: Protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research 47 (D1): D607–D613. https://doi.org/10.1093/nar/gky1131
- Tan Y, Jin Y, Wu X, Ren Z (2019). PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism. BMC Molecular Biology 20: 24. https://doi.org/10.1186/s12867-019-0141-z
- Wang C-Y, Li C-Y, Hsu H-P, Cho C-Y, Yen M-C et al. (2017). PSMB5 plays a dual role in cancer development and immunosuppression. American Journal of Cancer Research 7 (11): 2103–2120.
- Wang Y, Zhu M, Li J, Xiong Y, Wang J et al. (2021). Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU). Cell Death & Disease 12 (7): 1–11. https:// doi.org/10.1038/s41419-021-03960-w
- Wu J, Qian J, Li C, Kwok L, Cheng F et al. (2010). MiR-129 regulates cell proliferation by downregulating CDK6 expression. Cell Cycle (Georgetown, Tex.) 9: 1809–1818. https://doi. org/10.4161/cc.9.9.11535
- Xia J, Wang H, Li S, Wu Q, Sun L et al. (2017). Ion channels or aquaporins as novel molecular targets in gastric cancer. Molecular Cancer 16 (1): 54. https://doi.org/10.1186/s12943- 017-0622-y
- Xia Q, Cai Y, Peng R, Wu G, Shi Y et al. (2014). The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition. International Journal of Oncology 44 (3): 735–744. https://doi.org/10.3892/ ijo.2013.2240
- Yazdi N, Houshmand M, Atashi A, Kazemi A, Najmedini AA et al. (2018). Long noncoding RNA PVT1: Potential oncogene in the development of acute lymphoblastic leukemia. Turkish Journal of Biology 42 (5): 405–413. https://doi.org/10.3906/biy-1801- 46
- Ying X, Che X, Wang J, Zou G, Yu Q et al. (2021). CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer. Journal of Cancer 12 (8): 2206–2215. https://doi.org/10.7150/ jca.51139
- Yu G, He Q-Y (2016). ReactomePA: An R/Bioconductor package for reactome pathway analysis and visualization. Molecular BioSystems 12 (2): 477–479. https://doi.org/10.1039/ C5MB00663E
- Yu G, Wang L-G, Han Y, He Q-Y (2012). clusterProfiler: An R package for comparing biological themes among gene clusters. Omics: A Journal of Integrative Biology 16 (5): 284–287. https://doi. org/10.1089/omi.2011.0118
- Zhang X, Zhang Q, Zhang K, Wang F, Qiao X et al. (2021). Circ SMARCA5 Inhibited Tumor Metastasis by Interacting with SND1 and Downregulating the YWHAB Gene in Cervical Cancer. Cell Transplantation 30: 0963689720983786. https:// doi.org/10.1177/0963689720983786
- Zheng D-L, Huang Q-L, Zhou F, Huang Q-J, Lin J-Y et al. (2012). PA28β regulates cell invasion of gastric cancer via modulating the expression of chloride intracellular channel 1. Journal of Cellular Biochemistry 113 (5): 1537–1546. https://doi. org/10.1002/jcb.24022
- Zhi D, Zhou K, Yu D, Fan X, Zhang J et al. (2019). HERG1 is involved in the pathophysiological process and inhibited by berberine in SKOV3 cells. Oncology Letters 17 (6): 5653–5661. https://doi. org/10.3892/ol.2019.10263
- Zhou Q, McCracken MA, Strobl JS (2002). Control of Mammary Tumor Cell Growth in Vitro by Novel Cell Differentiation and Apoptosis Agents. Breast Cancer Research and Treatment 75 (2): 107–117. https://doi.org/10.1023/A:1019698807564
- Zhou Y, Liu S, Luo Y, Zhang M, Jiang X et al. (2020). IncRNA MAPKAPK5-AS1 promotes proliferation and migration of thyroid cancer cell lines by targeting miR-519e-5p/YWHAH. European Journal of Histochemistry: EJH 64 (4). https://doi. org/10.4081/ejh.2020.3177
- Zhu X, Li Y, Shen H, Li H, Long L et al. (2013). MiR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. FEBS Letters 587 (1): 73–81. https://doi.org/10.1016/j. febslet.2012.11.004
- Zhuang S, Li L, Zang Y, Li G, Wang F (2020). RRM2 elicits the metastatic potential of breast cancer cells by regulating cell invasion, migration and VEGF expression via the PI3K/ AKT signaling. Oncology Letters 19 (4): 3349. https://doi. org/10.3892/ol.2020.11428
| APA | YAVUZ M, Sahin B, Baykal A, Demircan T (2023). Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. , 44 - 60. 10.55730/1300-0152.2640 |
| Chicago | YAVUZ Mervenur,Sahin Betul,Baykal Ahmet Tarik,Demircan Turan Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. (2023): 44 - 60. 10.55730/1300-0152.2640 |
| MLA | YAVUZ Mervenur,Sahin Betul,Baykal Ahmet Tarik,Demircan Turan Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. , 2023, ss.44 - 60. 10.55730/1300-0152.2640 |
| AMA | YAVUZ M,Sahin B,Baykal A,Demircan T Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. . 2023; 44 - 60. 10.55730/1300-0152.2640 |
| Vancouver | YAVUZ M,Sahin B,Baykal A,Demircan T Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. . 2023; 44 - 60. 10.55730/1300-0152.2640 |
| IEEE | YAVUZ M,Sahin B,Baykal A,Demircan T "Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis." , ss.44 - 60, 2023. 10.55730/1300-0152.2640 |
| ISNAD | YAVUZ, Mervenur vd. "Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis". (2023), 44-60. https://doi.org/10.55730/1300-0152.2640 |
| APA | YAVUZ M, Sahin B, Baykal A, Demircan T (2023). Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. Turkish Journal of Biology, 47(1), 44 - 60. 10.55730/1300-0152.2640 |
| Chicago | YAVUZ Mervenur,Sahin Betul,Baykal Ahmet Tarik,Demircan Turan Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. Turkish Journal of Biology 47, no.1 (2023): 44 - 60. 10.55730/1300-0152.2640 |
| MLA | YAVUZ Mervenur,Sahin Betul,Baykal Ahmet Tarik,Demircan Turan Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. Turkish Journal of Biology, vol.47, no.1, 2023, ss.44 - 60. 10.55730/1300-0152.2640 |
| AMA | YAVUZ M,Sahin B,Baykal A,Demircan T Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. Turkish Journal of Biology. 2023; 47(1): 44 - 60. 10.55730/1300-0152.2640 |
| Vancouver | YAVUZ M,Sahin B,Baykal A,Demircan T Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. Turkish Journal of Biology. 2023; 47(1): 44 - 60. 10.55730/1300-0152.2640 |
| IEEE | YAVUZ M,Sahin B,Baykal A,Demircan T "Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis." Turkish Journal of Biology, 47, ss.44 - 60, 2023. 10.55730/1300-0152.2640 |
| ISNAD | YAVUZ, Mervenur vd. "Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis". Turkish Journal of Biology 47/1 (2023), 44-60. https://doi.org/10.55730/1300-0152.2640 |
